Top Markets
#1 CoW Protocol CoW Protocol +59.73%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.71%
#4 Cysic Cysic +31.67%
#5 Walrus Walrus +25.77%
#6 Humanity Humanity +22.30%
#7 Enso Enso +18.12%
#8 Velvet Velvet +17.00%
#9 Tutorial Tutorial +15.35%
#10 The Black Bull The Black Bull +13.56%
Coin of the day
CoW Protocol CoW Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
ViewRay, Inc. ViewRay, Inc.

ViewRay, Inc.

VRAY
Classement en actions #37058
ViewRay, Inc. specializes in the development, production, and global... ViewRay, Inc. specializes in the development, production, and global distribution of advanced radiation therapy systems that leverage magnetic resonance imaging (MRI). These integrated systems are utilized to both image and deliver treatment for cancer patients in various countries, including the United States, France, Taiwan, and the United Kingdom. The company's key product, MRIdian, is an MRI-guided radiation therapy solution engineered to address critical concerns during treatment, such as beam distortion and potential skin toxicity. ViewRay's client base spans a diverse range of medical facilities, including university research and teaching hospitals, local community hospitals, private medical practices, government institutions, and independent cancer treatment centers. MRIdian systems are sold to these clients via ViewRay's direct sales force and through its established distribution channels. The company was founded in 2004 and operates out of its main office in Oakwood, Ohio.
Prix de l'action
$0.014
Dernière synchronisation: 2023-08-21
Capitalisation boursière
$2.07M
Changement (1 jour)
-1.41%
Changement (1 an)
0.00%
Pays
US
Échange ViewRay, Inc. (VRAY)

Catégorie

Healthcare
Revenus pour ViewRay, Inc. (VRAY)
Revenus en Aug 2026 TTM : 0
Selon les derniers rapports financiers de ViewRay, Inc., le chiffre d'affaires actuel de l'entreprise (TTM) est de 0. En 2026, l'entreprise a réalisé un chiffre d'affaires de 0 égal à le chiffre d'affaires de l'année 2026, qui était de 0. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour ViewRay, Inc. de 2026 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
Pas assez de données pour les dates fournies.
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US